Kenyon, Christopher
2 papers on CoChat
Most cited papers
- Verified
Risk factors for HCV acquisition among HIV-positive MSM in Belgium.
Apers, L., Vanden Berghe, W., De Wit, S., Kabeya, K., Callens, S., Buyze, J., Kenyon, C., Florence, E., & Buvé, A. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes
Hepatitis C virus researchHIV, Drug Use, Sexual Risk
Cited by 60
- Verified
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial
Moyle, G., Assoumou, L., de Castro, N., Post, F. A., Curran, A., Rusconi, S., De Wit, S., Stephan, C., Raffi, F., Johnson, M., et al. (2024) · The Lancet HIV
HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free